Sachi Morita

Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes

Megumi Inada, M. Sato, Sachi Morita et al. · International Journal of Clinical Pharmacology and Therapeutics · 2010 · 61 citations

Phase I dose-escalating study of panobinostat (LBH589) Administered intravenously to Japanese patients with advanced solid tumors

Sachi Morita, Satoshi Oizumi, Hironobu Minami et al. · Investigational New Drugs · 2011 · 42 citations

Oncology, Dose-escalating Study, Pharmacology +6

The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan

Kuniko Sunami, Yoichi Naito, Eriko Aimono et al. · International Journal of Clinical Oncology · 2021 · 40 citations · Full text

Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer

Tomoyo Oguri, Ayako Mitsuma, Megumi Inada‐Inoue et al. · International Journal of Clinical Pharmacology and Therapeutics · 2013 · 37 citations

Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer

Sachi Morita, Keisuke Uehara, Goro Nakayama et al. · Cancer Chemotherapy and Pharmacology · 2012 · 34 citations

Bevacizumab-related Hypertension, Medicine, Genetic Epidemiology +9